Figure 1. Detailed changes of surface markers on the BMDCs after treatment with IL-2.
Figure 2. Assay for treated BMDCs to drive T cells.
Figure 3. Localization of phagocytosis by BMDC.
Figure 4. Phagocytosis study.
Figure 5. ACP activity measurement.
Figure 6. Secretion of IL-12 and TNF-α by BMDCs.
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
